Clinical Trials Directory

Trials / Completed

CompletedNCT00543140

Post Implantation/Post Market Evaluation of the Swedish Adjustable Gastric Band

A Post Implantation/Post Market Evaluation of Safety and Quality of Life in Subjects Implanted With the Swedish Adjustable Gastric Band (SAGB) During Protocol CI-02-0006

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
303 (actual)
Sponsor
Ethicon Endo-Surgery · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the long term safety of the Swedish Adjustable Gastric Band (SAGB) in subjects with an SAGB in place. Specifically it is designed to determine the re-operation rate (band revision, band replacement and explants resulting from serious adverse device-related event {SADE}) of gastric banding at 4 and 5 year post implant.

Detailed description

NCT00543140 (CI-06-0001) is the 2 year Safety and QOL subject follow-up study to NCT00166205 (CI-02-0006), completed on November 10, 2008. As a condition of approval, the FDA required additional subjects with long-term safety data. These subjects enrolled under protocol CI-07-0006 (NCT00813462)-5 Year Post-Approval Study With the REALIZE (TM) Adjustable Gastric Band. Protocol CI-06-0001 was amended to combine these study subjects with study subjects from CI-07-0006. NCT00543140 (CI-06-0001) will not be completed (analysis of results) until the additional subjects in NCT00813462 (CI-07-0006) complete this study since the original intent was to pool the data together from the above two studies to obtain the appropriate sample size for estimation of the re-operation rate at 4 and 5 years post implantation.

Conditions

Interventions

TypeNameDescription
DEVICEREALIZE™ Swedish Adjustable Gastric BandLaparoscopic placement of the Swedish Adjustable Gastric Band

Timeline

Start date
2006-08-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2007-10-12
Last updated
2016-03-09
Results posted
2016-03-09

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00543140. Inclusion in this directory is not an endorsement.